Jonsson Comprehensive Cancer Center
Bortezomib and Rituximab in Treating Patients With Non-Hodgkin's Lymphoma
- First Posted Date
- 2004-10-08
- Last Posted Date
- 2012-10-04
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 15
- Registration Number
- NCT00093769
- Locations
- 🇺🇸
Jonsson Comprehensive Cancer Center at UCLA, Los Angeles, California, United States
Antithymocyte Globulin and Cyclosporine in Preventing Graft-Versus-Host Disease in Patients Undergoing Chemotherapy With or Without Radiation Therapy Followed By Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia
- Conditions
- Graft Versus Host DiseaseLeukemia
- First Posted Date
- 2004-10-08
- Last Posted Date
- 2013-11-06
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Registration Number
- NCT00093587
- Locations
- 🇺🇸
Jonsson Comprehensive Cancer Center at UCLA, Los Angeles, California, United States
Fludarabine in Treating Patients With Steroid-Resistant Chronic Graft- Versus-Host Disease
- Conditions
- Graft Versus Host Disease
- First Posted Date
- 2004-09-16
- Last Posted Date
- 2013-12-18
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Registration Number
- NCT00004194
Warfarin and Vatalanib in Treating Patients With Advanced Solid Tumors
- Conditions
- Unspecified Adult Solid Tumor, Protocol Specific
- Interventions
- First Posted Date
- 2004-09-09
- Last Posted Date
- 2020-08-05
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 24
- Registration Number
- NCT00091299
- Locations
- 🇺🇸
Jonsson Comprehensive Cancer Center at UCLA, Los Angeles, California, United States
Gemcitabine, Cisplatin, and Dexamethasone in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
- Conditions
- Lymphoma
- First Posted Date
- 2004-09-08
- Last Posted Date
- 2013-01-08
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 1
- Registration Number
- NCT00090909
- Locations
- 🇺🇸
Jonsson Comprehensive Cancer Center at UCLA, Los Angeles, California, United States
CP-675,206 (CTLA4-Blocking Monoclonal Antibody) Combined With Dendritic Cell Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed With Surgery
- Conditions
- Melanoma (Skin)
- Interventions
- Biological: maximum tolerated dose of anti-cytotoxic T-lymphocyte-associated antigen-4 monoclonal antibody
- First Posted Date
- 2004-09-08
- Last Posted Date
- 2020-08-03
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 18
- Registration Number
- NCT00090896
- Locations
- 🇺🇸
Jonsson Comprehensive Cancer Center at UCLA, Los Angeles, California, United States
Granisetron to Prevent Nausea and Vomiting After Chemotherapy in Patients With Malignant Disease
- Conditions
- Unspecified Adult Solid Tumor, Protocol Specific
- First Posted Date
- 2004-08-23
- Last Posted Date
- 2014-01-06
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Registration Number
- NCT00005024
Erlotinib and Green Tea Extract (Polyphenon® E) in Preventing Cancer Recurrence in Former Smokers Who Have Undergone Surgery for Bladder Cancer
- Conditions
- Bladder Cancer
- Interventions
- First Posted Date
- 2004-08-05
- Last Posted Date
- 2020-07-31
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 17
- Registration Number
- NCT00088946
- Locations
- 🇺🇸
Santa Monica UCLA Medical Center, Santa Monica, California, United States
🇺🇸Veterans Affairs Medical Center - West Los Angeles, Los Angeles, California, United States
🇺🇸Mayo Clinic Cancer Center, Rochester, Minnesota, United States
Irinotecan in Treating Patients With Esophageal or Stomach Cancer
- Conditions
- Esophageal CancerGastric Cancer
- Interventions
- First Posted Date
- 2004-07-22
- Last Posted Date
- 2020-08-03
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 40
- Registration Number
- NCT00003748
- Locations
- 🇺🇸
Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States
🇺🇸Cancer Care Associates Medical Group, Torrance, California, United States
🇺🇸UCLA Cancer Center - Santa Clarita, Valencia, California, United States
Amifostine Plus Irinotecan in Treating Patients With Metastatic Colorectal Cancer
- Conditions
- Colorectal Cancer
- Interventions
- First Posted Date
- 2004-07-21
- Last Posted Date
- 2020-08-03
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 23
- Registration Number
- NCT00003225
- Locations
- 🇺🇸
Wilshire Oncology Medical Group, Inc., Rancho Cucamonga, California, United States
🇺🇸Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States